Geoffrey M. Parker Allogene Therapeutics, Inc. (ALLO) insider trading activity

Geoffrey M. Parker is CHIEF FINANCIAL OFFICER of Allogene Therapeutics, Inc.. Currently has a direct ownership of 1.3 Million shares of ALLO, which is worth approximately $2.82 Million. The most recent transaction as insider was on Feb 03, 2025, when has been sold 4,361 shares (Common Stock) at a price of $1.73 per share, resulting in proceeds of $7,544. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.3M

14.98% 3M change

58.8% 12M change

Total Value Held $2.82 Million

Geoffrey M. Parker Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 03 2025	SELL Open market or private sale	$7,544 $1.73 p/Share	4,361 Reduced 0.33%	1,301,540 Common Stock
Jan 24 2025	BUY Grant, award, or other acquisition	-	173,913 Added 11.75%	1,305,901 Common Stock
Oct 21 2024	SELL Payment of exercise price or tax liability	$103,387 $2.84 p/Share	36,404 Reduced 3.12%	1,131,988 Common Stock
May 16 2024	BUY Grant, award, or other acquisition	$1,000,001 $2.9 p/Share	344,828 Added 22.85%	1,164,418 Common Stock
Jan 30 2024	BUY Open market or private purchase	$684 $3.6 p/Share	190 Added 0.02%	819,590 Common Stock
Jan 25 2024	BUY Grant, award, or other acquisition	-	29,400 Added 3.46%	819,400 Common Stock
Oct 16 2023	BUY Grant, award, or other acquisition	-	790,000 Added 50.0%	790,000 Common Stock

Also insider at

TCDA

Tricida, Inc. Healthcare

COO, CFO and EVP

CCXI

ChemoCentryx, Inc.

Director

PRGO

PERRIGO Co plc Healthcare

Director

BTTX

Better Therapeutics, Inc. Healthcare

GMP